K. VijayRaghavan

Results: 5



#Item
1Science and technology in India / Institute for Stem Cell Biology and Regenerative Medicine / K. VijayRaghavan / NCBS / India / Bangalore / Indian Institute of Technology Kanpur

IFOM: A YEAR IN REVIEWConnecting Science: the agreement between IFOM

Add to Reading List

Source URL: review.ifom.eu

Language: English - Date: 2014-05-08 04:43:16
2Pharmacy / Biosimilar / Clinical research / Pharmaceutical industry in India / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry

Trends in Medical Technologies Innovation in Middle-Income Countries • K. VijayRaghavan, Secretary, Government of India, Department of Biotechnology • WHO-WIPO-WTO, Geneva, Wednesday 5 November 2014

Add to Reading List

Source URL: wto.org

Language: English - Date: 2014-11-10 11:38:33
3Pharmacy / Biosimilar / Clinical research / Pharmaceutical industry in India / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry

Trends in Medical Technologies Innovation in Middle-Income Countries • K. VijayRaghavan, Secretary, Government of India, Department of Biotechnology • WHO-WIPO-WTO, Geneva, Wednesday 5 November 2014

Add to Reading List

Source URL: www.wto.org

Language: English - Date: 2014-11-10 11:38:33
4

Trends in Medical Technologies Innovation in Middle-Income Countries • K. VijayRaghavan, Secretary, Government of India, Department of Biotechnology • WHO-WIPO-WTO, Geneva, Wednesday 5 November 2014

Add to Reading List

Source URL: www.wto.int

Language: English - Date: 2014-11-10 11:38:33
    5Pharmacy / Biosimilar / Clinical research / Pharmaceutical industry in India / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry

    Trends in Medical Technologies Innovation in Middle-Income Countries • K. VijayRaghavan, Secretary, Government of India, Department of Biotechnology • WHO-WIPO-WTO, Geneva, Wednesday 5 November 2014

    Add to Reading List

    Source URL: www.wto.org

    Language: English - Date: 2014-11-10 11:38:33
    UPDATE